BB- I plan to vote for the additional comp to help make the litigation as you described go away. I don’t want any distractions for this management team.
Second, hoping the NDA has expired, I anticipate an extremely positive ASM with at least one material milestone announced near the ASM. I expect bullish discussion of the franchise model, Eden’s, partnering, new trials and touching on uplist and Direct.
If MHRA has not yet green lighted L, then I expect they’ll do the best they can to describe approval timing.
Best ASM yet is 5 weeks away and very much looking forward to it.